Preclinical insights reveal how investigational agents may address myocardial damage in ischemic heart disease, suggesting new therapeutic avenues.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ossola et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: